News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>BOCI Raises JD HEALTH TP to HKD47, Rating Buy
BOCI released a research report, covering JD HEALTH (06618.HK), which charted a 25% YoY revenue growth in 1Q25, with an adjusted NPM of 10.6%, marking a historical high.The broker ...
Reset
Send
The window will close in 5 seconds
<Research>BOCI Raises JD HEALTH TP to HKD47, Rating Buy
Close
Recommend
17
Positive
23
Negative
7
 
SHORT SELL
 
STOCK INFO

BOCI released a research report, covering JD HEALTH (06618.HK)  -0.300 (-0.724%)    Short selling $134.50M; Ratio 26.947%   , which charted a 25% YoY revenue growth in 1Q25, with an adjusted NPM of 10.6%, marking a historical high.

The broker envisioned JD Health will steadfastly execute its 2025 investment plan and enhance investments in multiple areas starting from 2Q25.

Related NewsCICC Lists HSTECH Constituent Adjustments/ Weighting Changes/ Passive Capital Change Forecasts (Table)
Therefore, although the broker raised the group's revenue forecast by 2%, it maintained its forecast of RMB2.7 billion adjusted operating profit for 2025 and lifted the target price from HKD45 to HKD47, maintaining a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-22 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.